Who is at risk for alopecia

Hair loss usually begins a few months after they start treatment. This type of hair loss usually means that the drug is working.

You can treat this hair loss with a corticosteroid that you apply to the bald spots. It allows the hair to regrow without stopping cancer treatment. Your race may also affect your risk of getting alopecia areata. In a large study, researchers found that black and Hispanic nurses were more likely than non-Hispanic white nurses to develop this disease. While this study spanned several years, it has many limitations.

For example, it only looked at women nurses in the United States. More research is needed to know whether this finding holds true for other people. You can get alopecia areata at any age; however, most people develop it by 30 years of age. For many, the disease begins during childhood or the teenage years.

For some people, regrowth will happen without any help. Because alopecia areata cannot be cured, people who have regrowth can have more hair loss later. Some people have cycles of hair loss and regrowth. There are many treatments for alopecia areata, and scientists are studying new possibilities. To see the treatment options, go to Alopecia areata: Diagnosis and treatment.

Lakhmiri M, Cavelier-Balloy B, et al. Lee S, Lee H, et al. Tel: , Fax: , rk. This article has been cited by other articles in PMC. Abstract Background Alopecia areata is the most common cause of localized, nonscarring alopecia. Objective This study strived to investigate the differences in clinical profiles according to disease severity and to determine risk factors for severe alopecia areata. Methods A total of 1, patients from to were analyzed retrospectively.

Results Eight hundred eighty-three patients were in the mild-to-moderate alopecia areata group and patients were in the severe group. Conclusion This is the largest case analysis in Korean patients with alopecia areata. Methods This study retrospectively analyzed the medical records and clinical photographs.

Variable Value Number of patients male:female Mean age yr Open in a separate window. Table 2 Characteristics of patients with AA according to severity. Laboratory results Of the 1, total patients, patients had laboratory blood test results: in the mild-to-moderate group and in the severe group.

Table 3 Laboratory findings and autoantibodies in patients with AA. Analysis of risk factors To determine the risk factors of severe AA, the statistically significant factors of severe AA were analyzed by logistic regression analysis Table 4. Table 4 Risk factors for severe alopecia areata. References 1.

Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients. Ann Dermatol Venereol.

Alopecia areata. N Engl J Med. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J Eur Acad Dermatol Venereol. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide populationbased study. Friedmann PS. Alopecia areata and auto-immunity.

Br J Dermatol. Mayo Clin Proc. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. Alopecia areata: a long term follow-up study of patients. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. Profile of alopecia areata in Northern India. Int J Dermatol. The epidemiology of childhood alopecia areata in China: a study of patients. Pediatr Dermatol. A clinical study of childhood alopecia areata in Singapore.

Analysis the prognostic factors of alopecia areata. Korean J Dermatol. The pattern and profile of alopecia areata in Singapore--a study of Asians. Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study. Clin Exp Dermatol. Differences in comorbidity profiles between early-onset and late-onset alopecia areata patients: a retrospective study of Korean patients.

An evaluation of patients. Arch Dermatol. Nail changes in Indian patients with alopecia areata. Stimulation of ectodermal organ development by Ectodysplasin-A1. Dev Biol. Early intervention with high-dose steroid pulse therapy prolongs disease-free interval of severe alopecia areata: a retrospective study. Alopecia areata as a model for T cell-dependent autoimmune diseases.

Choices are: Medications Medicines may be given to help regrow hair, such as: Corticosteroids Minoxidil Medicine to suppress the immune system Procedures Procedures may be an option if medicines do not work.

Some choices are: Laser therapy to stimulate hair growth Hair transplant surgery Medical tattooing to give the appearance of eyebrows Other Treatments Hair loss can cause social anxiety for some. Prevention There are no known guidelines to prevent this health problem. Ostrovsky, MD Cancer Care.

Emergency Services. Cesarean Birth. Imaging Services. High Blood Pressure. Laboratory Services. Maternity Services. Hip Replacement. Primary Care. Type 2 Diabetes. Surgical Services. Home Care. Support Groups. Stroke Awareness. Fitness Classes. Integrative Therapy. Weight Management. Parking Information. Gift Shop. Patient Meals. Pay My Bill Online.